Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to Pfizer's clinical trial data. The White House said it will be provided 'at no charge' https://t.co/pLqCovJwwU pic.twitter.com/qPQqYwnEFI— Reuters (@Reuters) December 23, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


